Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Marinus Pharmaceuticals Inc (MRNS)

  • Technical Exchange News
  • Feb. 11, 2025, 19:31 UTC
  • 53
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Bionano Genomics Inc (BNGO)

  • Technical Exchange News
  • Feb. 11, 2025, 02:53 UTC
  • 52
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Bionano Genomics Inc (BNGO)

  • Technical Exchange News
  • Feb. 10, 2025, 19:26 UTC
  • 52
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

NextCure Inc (NXTC)

  • Technical Exchange News
  • Feb. 08, 2025, 02:40 UTC
  • 55
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Indaptus Therapeutics Inc. (INDP)

  • Technical Exchange News
  • Feb. 08, 2025, 02:40 UTC
  • 56
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

NextCure Inc (NXTC)

  • Technical Exchange News
  • Feb. 07, 2025, 18:43 UTC
  • 63
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Indaptus Therapeutics Inc. (INDP)

  • Technical Exchange News
  • Feb. 07, 2025, 18:43 UTC
  • 64
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Revance Therapeutics (RVNC)

  • Technical Exchange News
  • Feb. 07, 2025, 09:12 UTC
  • 63
  • 0 comments

Revance Therapeutics (RVNC) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text

Revance Therapeutics (RVNC)

  • Technical Exchange News
  • Feb. 07, 2025, 08:29 UTC
  • 60
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Revance Therapeutics, Inc. - Common Stock.

Comment Full text

Revance Therapeutics (RVNC)

  • Technical Exchange News
  • Feb. 07, 2025, 08:29 UTC
  • 55
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Revance Therapeutics, Inc. - Common Stock. New value: Revance Therapeutics, Inc. - Common Stock.

Comment Full text
  • Previous
  • 317
  • 318
  • 319
  • 320
  • 321
  • Next

Search

News categories

  • Technical Exchange News(11417)
  • Event(3127)
  • SEC News(210687)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(136192)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin